Negative Pressure Wound Therapy Devices Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2020–2027

Negative Pressure Wound Therapy Devices Market by Product, Application, and End User : Global Opportunity Analysis and Industry Forecast, 2020–2027

  • May 2020 •
  • 261 pages •
  • Report ID: 5931839 •
  • Format: PDF
Negative Pressure Wound Therapy Devices Market by Product (Conventional NPWT Devices and Single Use NPWT Devices), Application (Chronic Wounds and Acute Wounds), and End User (Hospitals & Clinics, Ambulatory Surgery Centers (ASCs), and Home Care Settings): Global Opportunity Analysis and Industry Forecast, 2020–2027

The negative pressure wound therapy (NPWT) devices accounted for $2,144 million in 2020, and is expected to reach $3,347 million by 2027, registering a CAGR of 5.7% from 2020 to 2027.
Negative pressure wound therapy (NPWT) devices are one of the most commonly used therapies to treat acute and chronic wounds. These devices work by creating negative pressure around the wounds, which leads to the flowing out of exudate from the wound. In addition, NPWT devices promote wound healing, reduce recurrent use of dressings (as in case of traditional wound care), provide an efficient option for management of closed surgical incision lines, and improve patient well-being. These devices consist of a vacuum pump, drainage tubing, and a dressing set. Furthermore, in some cases the pump may be stationary or portable, which relies on battery power and allows regulation of suction strength. Moreover, these devices also have alarms to indicate loss of suction and have a replaceable collection canister. The dressing sets either contain foam or gauze dressing to be placed on wounds and an adhesive film drape for sealing wounds. Drainage tubes are available in multiple configurations depending on dressings used and wound being treated. These devices find their application in various types of wounds such as venous leg ulcers, burn wounds, trauma wounds, and incision wounds. For instance, in venous leg ulcers, the use of NPWT devices lead to reduction of edema and drainage of wound exudate.
Growth of the global NPWT devices market is majorly driven by increase in incidences of chronic diseases such as diabetes mellitus and obesity.
In addition, rise in patient awareness toward the availability of cost-effective NPWT devices such as single-use devices, and surge in number of casualties due to accidents & traumas also boost the market growth. Moreover, factors such as rise in geriatric population across the globe, who are highly susceptible to various medical conditions leading to formation of different types of wounds also boost the growth of the market. Moreover, availability of novel and advanced NPWT devices, which are patient-friendly and easy to use also fuel the growth of the negative pressure wound therapy devices market. However, lack of trained professionals and complications caused due to use of NPWT devices hinder the growth of the global market. On the contrary, increase in focus on advancements of treatment protocols, significant unmet needs in wound care field, and high market potential in untapped emerging economies are anticipated to serve as lucrative opportunities for the market expansion.
The global NPWT devices market is segmented on the basis of product, wound type, end user, and region. On the basis of product, it is bifurcated into single-use NPWT devices and conventional NPWT devices. As per wound type, it is categorized into chronic and acute wounds. The chronic wounds segment is further classified into pressure ulcers, diabetic foot ulcers, venous leg ulcers, and arterial ulcers. Similarly, the acute wounds segment is further divided into burns & trauma and surgical wounds. On the basis of end user, the market is segregated into hospitals & clinics, ambulatory surgery centers, and home care settings. Region wise, it is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
The major players in the negative pressure wound therapy devices market are 3M (Acelity L.P. Inc.,), ATMOS MedizinTechnik GmbH & Co. KG, Cardinal Health., ConvaTec Group Plc., DeRoyal Industries, Inc., Devon International Group, Investor AB (Mölnlycke Health Care AB), Olle Larsson Holding AG (Medela AG), Smith & Nephew Plc., and Talley group Ltd.

KEY BENEFITS FOR STAKEHOLDERS
• This report entails a detailed quantitative analysis along with the current global negative pressure wound therapy devices market trends from 2019 to 2027 to identify the prevailing opportunities along with the strategic assessments.
• The market size and estimations are based on a comprehensive analysis of key developments in the industry.
• A qualitative analysis based on innovative products facilitates strategic business planning.
• The development strategies adopted by the key market players are enlisted to understand the competitive scenario of the market

Key Market Segments
• By Product
o Conventional NPWT Devices
o Single Use NPWT Device
• By Application
o Chronic Wounds
- Pressure Ulcers
- Diabetic Foot Ulcers
- Venous Leg Ulcers
- Arterial Ulcers
o Acute Wounds
- Burns & Trauma
- Surgical Wounds
• By End User
o Hospitals & Clinics
o Ambulatory Surgery Centers (ASCs)
o Home Care Settings
• By Region
o North America
- U.S.
- Canada
- Mexico
o Europe
- Germany
- France
- UK
- Italy
- Rest of Europe
o Asia-Pacific
- Japan
- China
- India
- Rest of Asia-Pacific
o LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
• List of key players profiled in the report:
• 3M (Acelity L.P. Inc.,)
• ATMOS MedizinTechnik GmbH & Co. KG
• Cardinal Health.
• ConvaTec Group Plc.
• DeRoyal Industries, Inc.
• Devon International Group
• Investor AB (Mölnlycke Health Care AB)
• Olle Larsson Holding AG (Medela AG)
• Smith & Nephew Plc.
• Talley group Ltd.

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)
• Lohmann & Rauscher International GmbH & Co KG.
• Genadyne Biotechnologies, Inc.
• Alleva Medical Ltd.